3M Completes Sale of its Pharmaceuticals Business in Europe

03-Jan-2007

3M announced it has completed its transaction with Meda AB for the sale of 3M's pharmaceuticals business in Europe. Under the agreement, Meda AB will acquire regional marketing and intellectual property rights for 3M's branded pharmaceuticals, including Aldara, Tambocor, MetroGel-Vaginal and Minitran.

The transactions with Ironbridge Capital and Archer Capital for the sale of 3M's pharmaceutical operations in the Asia Pacific region; and Graceway Pharmaceuticals LLC for the sale of 3M's pharmaceutical operations in the United States, Canada, and Latin America were completed in the fourth quarter of 2006.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!